The Leading ECG Solution for Clinical Trials

Designed for patients and sites, onsite or remote, across all phases and therapeutic areas.

  • Fewer dropouts with lower patient burden

  • Real-time ECG anytime, anywhere

  • Cost-effective alternatives to traditional ECGs

TALK TO AN EXPERT

Cardiac safety issues still jeopardize trial success

Cardiac events are a top reason for trial delays and drug withdrawals.* Yet many approaches to ECG still limit accessibility, slow recruitment, and reduce compliance.

AliveCor delivers flexible ECG data capture without compromising quality or oversight.

VALIDATED AND TRUSTED GLOBALLY

5.4M+

lifetime users

300+

million ECGs recorded

40

countries with clinical trials

250+

clinical publications

Partner logo 1Partner logo 2Partner logo 3Partner logo 4Partner logo 5Partner logo 6Partner logo 7Partner logo 8Partner logo duplicate 1Partner logo duplicate 2Partner logo duplicate 3Partner logo duplicate 4Partner logo duplicate 5Partner logo duplicate 6Partner logo duplicate 7Partner logo duplicate 8
Partner logo 1Partner logo 2Partner logo 3Partner logo 4Partner logo 5Partner logo 6Partner logo 7Partner logo duplicate 1Partner logo duplicate 2Partner logo duplicate 3Partner logo duplicate 4Partner logo duplicate 5Partner logo duplicate 6Partner logo duplicate 7
Partner logo 1Partner logo 2Partner logo 3Partner logo 4Partner logo 5Partner logo 6Partner logo 7Partner logo duplicate 1Partner logo duplicate 2Partner logo duplicate 3Partner logo duplicate 4Partner logo duplicate 5Partner logo duplicate 6Partner logo duplicate 7

Flexible ECG solutions for every trial

  • Backed by over a decade of experience powering millions of ECGs with our Kardia ECG devices, AliveCor brings proven cardiac expertise into clinical trials.
  • Our trusted ECG technology is built to improve patient experience, simplify operations, and support accurate cardiac decision-making.
  • From real time data capture to AI-powered analysis, our solutions are designed to fit the needs of today’s trials without the complexity.

From Protocol to Submission

Unlock one complete, integrated suite of cardiac safety solutions, developed to support every phase of clinical trials through planning, recruitment, and retention.

Ensure consistency, compliance, and coordination across teams and sites.

Onsite or Remote

Across Phases and Therapeutic Areas

Three steps to simplify clinical trial ECGs

1. Record

Choose your device.

  • FDA-cleared 6-lead and 12-lead options
  • Heart data captured remotely or onsite
Km6l6LeadBadgeImage

6L Device

Learn More
Km6l6LeadBadgeImage

Kardia 12L

Learn More

2. Review and Analyze

Get instant data.

  • AI-powered algorithms deliver ECG results within seconds for review
  • CoreLab overread ensures accuracy, compliance, and additional insights

3. Deliver

Manage and submit.

  • Easily submit comprehensive ECG data reports
  • Supports confident risk assessment and submission workflows

CASE STUDY

Fully decentralized ME/CFS Phase II trial

Lindus Health needed a secure and patient-friendly ECG solution for a fully remote Phase 2 trial.

AliveCor delivered 6-lead devices with full-service support and regulatory-ready infrastructure.

  • Expanded patient access through remote ECG
  • Improved data collection and oversight
  • Strengthened regulatory confidence


Insights to guide confident trial decisions

Explore blogs, downloadable guides, and expert perspectives on how to improve cardiac safety and streamline execution.

"Their digital ECG solution enables trial design flexibility for follow-up visits, or even full decentralization, without impacting data quality."

Robert Kleiman

Chief Scientific & Regulatory Advisor, Cardiac Safety

"Working with AliveCor, we meet the real-world needs of patients and caregivers, driving tangible improvements in healthcare outcomes and research efficacy."

Matt Noble

SVP, Head of Patient Cloud

Choose AliveCor for your clinical trials.

Connect with us for a custom integration strategy that sets your research apart.

*Mamoshina, Polina et al. Cell Reports Medicine, Volume 2, Issue 3, 100216
**QT measurements made using EK12 ECG algorithm.